Table 2.
Incidence of AE and mortality in patients with both CPFE and lung cancer according to stage and treatment
| Total (n = 61) | AE (n = 10) | Mortality (n = 41) | |
| Stage | |||
| I | 18 | 3 | 10 |
| II | 6 | 1 | 2 |
| III | 12 | 3 | 9 |
| IV | 24 | 3 | 20 |
| Unknown | 1 | 0 | 0 |
| Treatment | |||
| Chemotherapy | 23 | 5 | 18 |
| Surgery | 17 | 3 | 10 |
| Radiation | 2 | 0 | 1 |
| Best supportive care | 11 | 0 | 8 |
| Surgery + adjuvant chemotherapy | 6 | 2 | 3 |
| Concurrent chemoradiation | 1 | 0 | 1 |
| Unknown | 1 | 0 | 0 |
AE, acute exacerbation; CPFE, combined pulmonary fibrosis and emphysema.